These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of sublingual immunotherapy on allergic inflammation: an update. Yacoub MR; Colombo G; Marcucci F; Caminati M; Sensi L; Di Cara G; Frati F; Incorvaia C Inflamm Allergy Drug Targets; 2012 Aug; 11(4):285-91. PubMed ID: 22506880 [TBL] [Abstract][Full Text] [Related]
9. Innate and lymphocytic response of birch-allergic patients before and after sublingual immunotherapy. Guida G; Boita M; Scirelli T; Bommarito L; Heffler E; Badiu I; Bellone G; Mietta S; Mistrello G; Rolla G Allergy Asthma Proc; 2012; 33(5):411-5. PubMed ID: 22762741 [TBL] [Abstract][Full Text] [Related]
10. Induction of tolerance via the sublingual route: mechanisms and applications. Moingeon P; Mascarell L Clin Dev Immunol; 2012; 2012():623474. PubMed ID: 22110534 [TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy mechanisms of action: the role of Th1 response. Ciprandi G; Tosca MA; Marseglia GL Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):9-12. PubMed ID: 19944003 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying the induction of regulatory T cells by sublingual immunotherapy. Tanaka Y; Fukumoto S; Sugawara S J Oral Biosci; 2019 Jun; 61(2):73-77. PubMed ID: 31109864 [TBL] [Abstract][Full Text] [Related]
13. Dose dependence of efficacy but not of safety in sublingual immunotherapy. Frati F; Incorvaia C; Marcucci F; Sensi L; Di Cara G; Puccinelli P; Dal Bo S Monaldi Arch Chest Dis; 2006 Mar; 65(1):38-40. PubMed ID: 16700192 [TBL] [Abstract][Full Text] [Related]
14. Advances of knowledge on allergic inflammation and the oral mucosa. Incorvaia C; Fuiano N; Frati F; Marcucci F Recent Pat Inflamm Allergy Drug Discov; 2014; 8(3):173-7. PubMed ID: 25487260 [TBL] [Abstract][Full Text] [Related]
15. Effects of sublingual immunotherapy on allergic inflammation. Incorvaia C; Frati F; Puccinelli P; Marcucci F; Di Cara G; Sensi L; Scurati S; Yacoub MR; Moingeon P Inflamm Allergy Drug Targets; 2008 Sep; 7(3):167-72. PubMed ID: 18782023 [TBL] [Abstract][Full Text] [Related]
16. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126 [TBL] [Abstract][Full Text] [Related]
17. Mucosal immunity and sublingual immunotherapy in respiratory disorders. Vitaliti G; Leonardi S; Miraglia Del Giudice M; Salpietro A; Artusio L; Caimmi D; Arrigo T; Salpietro C; Ciprandi G; La Rosa M J Biol Regul Homeost Agents; 2012; 26(1 Suppl):S85-93. PubMed ID: 22691255 [TBL] [Abstract][Full Text] [Related]
18. Local immunological mechanisms of sublingual immunotherapy. Allam JP; Novak N Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):571-8. PubMed ID: 22001742 [TBL] [Abstract][Full Text] [Related]
19. Allergen-specific immunotherapy: an update on immunological mechanisms of action. Ciprandi G; Marseglia GL; Tosca MA Monaldi Arch Chest Dis; 2006 Mar; 65(1):34-7. PubMed ID: 16700191 [TBL] [Abstract][Full Text] [Related]